Raise closed, search for fresh raises on Seedstage

Newport Beach, CA

Expanding AI-driven precision health solutions to enhance personalized wellness insights.

• Proven customer traction: Over 150,000 paying users and partnerships with 2,000+ healthcare professionals.
• Cutting-edge AI technology: Integrates genetic, lab, and lifestyle data for highly personalized health insights.
• Strong market positioning: Serving the growing digital health and personalized medicine industry.
• Innovative health solutions: Features AI-powered DecodyGPT, Longevity Screener, and precision recommendations.
• Recognized industry presence: Covered in peer-reviewed journals, NY Post, GenomeWeb, and other major media.

Genius Labs Company, operating as SelfDecode, is leveraging AI-driven technology to advance precision health through personalized genetic insights and data analysis. The company’s platform integrates genetic, lab, and lifestyle data to provide individuals with tailored health recommendations, helping them make informed decisions to optimize wellness and longevity. With a robust proprietary algorithm and a vast dataset analyzing over 200 million genetic variants, SelfDecode is positioned as a leader in digital health, offering AI-powered guidance through its Precision HealthGPT system. The company has built a growing customer base of over 150,000 paying users and has secured B2B partnerships with healthcare providers and wellness organizations.

This funding round aims to expand the platform’s capabilities, improve AI-driven health assessments, and scale user adoption in the digital health and wellness market. With continued enhancements to its AI and machine learning capabilities, SelfDecode seeks to further refine its health insights, strengthen data security, and grow its business-to-business and consumer outreach. Funds raised will be used to advance product development, increase marketing efforts, and expand research and development in predictive health analytics, ensuring that SelfDecode remains at the forefront of the precision health revolution.

Company Info

SelfDecode provides AI-driven precision health insights, analyzing genetic, lab, and lifestyle data to deliver personalized wellness recommendations.

SelfDecode, operated by Genius Labs Company, is a precision health platform leveraging AI-driven insights to provide personalized health recommendations. The company integrates genetic data, lab results, lifestyle factors, and individual health goals to generate tailored wellness strategies. Utilizing polygenic risk scoring, SelfDecode analyzes over 200 million genetic variants, surpassing traditional DNA analysis methods. The company’s AI-powered system, DecodyGPT, serves as a personal health coach, offering guidance on diet, supplements, and lifestyle modifications. SelfDecode also includes tools such as the Longevity Screener, Pharmacogenomics insights, and a Health Recommendations Engine, making advanced health analytics accessible to both individuals and healthcare professionals.

With a user base of over 150,000 paying customers and more than 2,000 doctors leveraging its technology, SelfDecode has established itself as a key player in the precision health industry. The company’s scalable platform serves both direct consumers and B2B clients, with partnerships in digital health, personalized medicine, and wellness. As the global market for personalized health and wellness expands—expected to surpass $5 trillion by 2028—SelfDecode is positioned to capitalize on this growth through continuous innovation in AI-driven health analytics. The company’s approach to preventative health aims to reduce reliance on reactive medical interventions, empowering individuals to take control of their well-being through data-driven decision-making.